New York, NY, November 16, 2009-Ebitda News reports that negative EBITDA for Osiris Therapeutics, Inc. (NASDAQ:OSIR) for its quarter ended September 30, 2009 was $(6,996,000), a 63% improvement over t ... read full story
Futures are pointing to an extension of yesterday's rally in the premarket on optimism that a deal to save Greece is near. An European plan to bail out Greece, led by Germany, is expected to be finalized today. Several European Union countries will b ... read full story